ABL Texcell Diagnostics SA

€2.44As of Sun 8 Nov 2026, 12:00 UTC
EPA:ABLDHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 4.51%
ROE 28.20%
Health Information Services
Beta (5Y) (0.52)
PE TTM 19.83
TSR TTM (43.17%)
Mkt cap €39.21M
ROIC 18.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.80
14.90%
(41.63%)
Buy 8|1|4|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.04
0.04
0.05
0.05
6.44%
7.38%
12.54%
16.57%
Revenue€M
3.649
3.591
3.771
3.860
9.97%
8.17%
8.73%
5.64%
Peers (US$44.03M)
Cap (US$)
PE
148.5M
9.664x
35.77M
—
12.18M
—
Capital
TTM
5Y
10Y
Leveragex
1.702
0.215
0.214
EBIT/Intx
0.737
0.307
0.275
Own earn%
(101.12)
(28.03)
(7.08)
Sh yield%
48.39
25.14
28.47
Owners
Insiders/Inst%
12.69
21.59
Short interest%
4.69
SBC / revenue%
1.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
13–18
$1 testx
—
Incr. ROIC%
6